Albemarle (ALB) Q4 2025 earnings summary

Executive summary

• Q4 2025 net sales reached $1.4B, up 16% year-over-year, with double-digit volume growth across all segments and adjusted EBITDA of $269M, up 7% year-over-year, driven by energy storage and cost improvements.

• Full-year 2025 net sales were $5.1B, with a 7% volume increase, adjusted EBITDA of $1.1B, and free cash flow of $692M, supported by cost/productivity gains and favorable sales mix.

• Significant cost and productivity improvements delivered, with $450M run-rate savings in 2025 and capex reduced by 65% to $590M.

• Strategic actions included the sale of Eurecat, planned sale of Ketjen, and idling of Kemerton Train 1 to enhance financial flexibility.

• 2026 outlook incorporates higher lithium demand, scenario-based guidance, and further cost improvements, with net sales projected between $4.1B–$7.8B and adjusted EBITDA between $0.9B–$4.4B depending on lithium price scenarios.

Financial highlights

• Q4 adjusted EBITDA margin decreased by 150 bps year-over-year to 19% due to FX and lower specialties margins, partially offset by energy storage and Ketjen.

• Q4 net loss was $414M, or $3.87 per diluted share, mainly due to tax and asset write-downs; adjusted diluted loss per share was $0.53, a 51% improvement year-over-year.

• FY 2025 net loss improved to $267M from a $1.18B loss in FY 2024; adjusted diluted EPS was $(0.79), a 66% improvement year-over-year.

• 2025 EBITDA to operating cash conversion was 117%, with free cash flow of $692M and underlying cash conversion at or above the long-term range of 60%-70%.

• Net debt to adjusted EBITDA stood at 2.0x at year-end, with $3.2B in available liquidity and $1.6B in cash.

Outlook and guidance

• 2026 guidance uses three lithium price scenarios ($10, $20, $30/kg LCE), with net sales expected between $4.1B–$7.8B and adjusted EBITDA between $0.9B–$4.4B.

• Targeting $100M–$150M in additional cost and productivity improvements and stable capital spending of $550–$600M in 2026.

• Energy Storage sales volumes expected to be flat or increase year-over-year in 2026; idling Kemerton Train 1 expected to be accretive to adjusted EBITDA from Q2 2026.

• Specialties business 2026 outlook: net sales $1.2–$1.4B, adjusted EBITDA $170–$230M, margins in the mid-teens; net sales expected flat to down, with lower adjusted EBITDA.

• Expecting positive free cash flow in 2026 if current lithium pricing persists.